In pancreatic cancer, we have demonstrated that approximately 50% of primary and established cell lines express high levels of IL-13Rα2 [24], and more than 70% of clinical specimens express high levels as well [3,25]. Here, IL13RA2 is linked to pancreatic neoplasm.